# Impact of Ascorbic Acid Treatment on the Development and Treatment of Vasodilation in Cardiac Surgery

> **NCT03744702** · EARLY_PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 15 (actual)

## Conditions studied

- Vasoplegia

## Interventions

- **DRUG:** Ascorbic Acid

## Key facts

- **NCT ID:** NCT03744702
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-28
- **Primary completion:** 2021-02-05
- **Final completion:** 2021-02-05
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2021-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03744702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03744702, "Impact of Ascorbic Acid Treatment on the Development and Treatment of Vasodilation in Cardiac Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03744702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*